Form 4: CSW Industrials CEO Joseph Armes Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
CSW Industrials' Chairman, President & CEO, Joseph Armes, executed multiple sales of common stock on September 16, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On September 16, 2024, Joseph B Armes, Chairman, President & CEO of CSW Industrials, sold shares of CSWI common stock.
- The sales were executed under a 10b5-1 trading plan established on November 17, 2023.
- A total of 1,000 shares were sold at prices ranging from $336.28 to $345.24.
- The transactions resulted in a decrease in Mr. Armes' direct holdings of CSWI common stock to 51,579 shares.
- Mr. Armes also indirectly owns 1,500 shares through JBA Family Partners, L.P. and 3,140 shares through an ESOP.
- Mr. Armes also holds performance rights that vest based on the company's total shareholder return compared to the Russell 2000 Index, as well as restricted stock units that vest upon the hiring and first employment anniversary of a successor CEO.
Sentiment
Score: 5
Explanation: The document is a standard Form 4 filing, indicating insider stock sales under a pre-arranged plan. It doesn't inherently convey positive or negative sentiment, hence a neutral score.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's future performance.
Industry Context
Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on any specific non-public information. Investors often monitor insider transactions for signals about a company's prospects, but sales under a 10b5-1 plan are generally viewed as less informative.
Key Dates
| Date | Description |
|---|---|
| 2023-11-17 | Date the 10b5-1 trading plan was established. |
| 2022-04-01 | Start date of a three-year performance cycle for performance rights, ending March 31, 2025. |
| 2023-04-01 | Start date of a three-year performance cycle for performance rights, ending March 31, 2026. |
| 2024-04-01 | Start date of a three-year performance cycle for performance rights, ending March 31, 2027. |
| 2024-09-16 | Date of the reported stock sales. |
| 2025-03-31 | End date of a performance cycle for performance rights. |
| 2025-03-31 | End date of a performance cycle for performance rights. |
| 2025-04-26 | Earliest date 40% of restricted stock units vest, contingent on hiring a successor CEO. |
| 2026-03-31 | End date of a performance cycle for performance rights. |
| 2027-03-31 | End date of a performance cycle for performance rights. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.